Therapeutic activity of a new KRASG12C inhibitor JMKX001899 in brain metastases: Preclinical models of KRASG12C-mutant non-small cell lung cancer

被引：0
|
作者：
He, Danming
Wang, Jie
Zhu, Yixiang
Zhong, Jia
Bai, Hua
机构：
[1] Chinese Acad Med Sci, State Key Lab Mol Oncol, CAMS Key Lab Translat Res Lung Canc,Canc Hosp, Natl Canc Ctr,Natl Clin Res Ctr Canc,Dept Med Onc, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp,State Key Lab Mo, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8630
引用
收藏
页数：1
相关论文
共 50 条
  • [1] In Situ RAS:RAF Binding Correlates with Response to KRASG12C Inhibitors in KRASG12C-Mutant Non-Small Cell Lung Cancer
    Kato, Ryoji
    Solanki, Hitendra S.
    Ozakinci, Hilal
    Desai, Bina
    Gundlapalli, Harika
    Yang, Yu Chi
    Aronchik, Ida
    Singh, Mallika
    Johnson, Joseph
    Marusyk, Andriy
    Boyle, Theresa A.
    Haura, Eric B.
    CLINICAL CANCER RESEARCH, 2025, 31 (06) : 1150 - 1162
  • [2] Sotorasib: a KRASG12C inhibitor for non-small cell lung cancer
    Ganguly, Arghya
    Yoo, Euna
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (06) : 536 - 537
  • [3] SOTORASIB IS ACTIVE IN KRASG12C-MUTANT NON-SMALL CELL LUNG CANCER
    Skoulidis, F.
    Li, B. T.
    Dy, G. K.
    Price, T. J.
    Falchook, G. S.
    Wolf, J.
    CANCER DISCOVERY, 2021, 11 (08) : 1870 - 1870
  • [4] KRASG12C inhibition enhances immunogenicity in KRASG12C-mutant colorectal cancer
    Patel, Parasvi S.
    Tian, Jun
    de la Cruz, Ferran Fece
    Curtis, Jacquelyn
    Panda, Apekshya
    Oka, Tomonori
    Demehri, Shadmehr
    Sade-Feldman, Moshe
    Koptez, Scott
    Corcoran, Ryan B.
    CANCER RESEARCH, 2024, 84 (07)
  • [5] Advances in the treatment of KRASG12C mutant non-small cell lung cancer
    Shaverdashvili, Khvaramze
    Burns, Timothy F.
    CANCER, 2025, 131
  • [6] Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non-Small Cell Lung Cancer
    Sabari, Joshua K.
    Velcheti, Vamsidhar
    Shimizu, Kazuhide
    Strickland, Matthew R.
    Heist, Rebecca S.
    Singh, Mohini
    Nayyar, Naema
    Giobbie-Hurder, Anita
    Digumarthy, Subba R.
    Gainor, Justin F.
    Rajan, Anant P.
    Nieblas-Bedolla, Edwin
    Burns, Aaron C.
    Hallin, Jill
    Olson, Peter
    Christensen, James G.
    Kurz, Sylvia C.
    Brastianos, Priscilla K.
    Wakimoto, Hiroaki
    CLINICAL CANCER RESEARCH, 2022, 28 (15) : 3318 - 3328
  • [7] Mechanisms of resistance to KRASG12C inhibitors in KRASG12C-mutated non-small cell lung cancer
    Chour, Ali
    Toffart, Anne-Claire
    Berton, Elodie
    Duruisseaux, Michael
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [8] Evaluation of KRASG12C inhibitor responses in novel murine KRASG12C lung cancer cell line models
    Sisler, Daniel J.
    Hinz, Trista K.
    Le, Anh T.
    Kleczko, Emily K.
    Nemenoff, Raphael A.
    Heasley, Lynn E.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Resistance to KRASG12C Inhibitors in Non-Small Cell Lung Cancer
    Blaquier, Juan Bautista
    Cardona, Andres Felipe
    Recondo, Gonzalo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] KRASG12C inhibitor resistance in patient-derived non-small cell lung cancer models
    Rosen, Joshua C.
    Nhu-An Pham
    Li, Quan
    Cao, Pinjiang
    Hueniken, Katrina
    Koga, Takamasa
    Radulovich, Nikolina
    Koers, Alex
    Niedbala, Michael
    Ross, Sarah
    Sacher, Adrian
    Tsao, Ming-Sound
    CANCER RESEARCH, 2024, 84 (06)
12345